|
Personalized Disease Management
We understand that every patient is unique and individualized treatment is often necessary. We strive to help physicians improve patient outcome through personalized therapy. Our passion is slowing and ultimately preventing the progression of autoimmune diseases and its associated disabilities.
To address this need, Glycominds offers diagnostic and prognostic tests that give physicians additional information to guide treatment decisions for patients with Multiple Sclerosis and Crohn's Disease.
|
|
|
|
 |
|
A New Way to Identify Patients
Likely to have Multiple Sclerosis
www.gms.net |
 |
|
Individualized Risk Assessment
of Complicated Crohn's Patients
www.ibdx.net |
|
